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Recently, disturbingly high levels of acrylamide were unexpectedly detected in widely consumed food items, notably French fries,
potato crisps, and bread. Much international public concern arose since acrylamide has been classified as a probable carcinogen,
although based chiefly on laboratory evidence; informative human data are largely lacking. We reanalysed a population-based Swedish
case–control study encompassing cases with cancer of the large bowel (N¼591), bladder (N¼263) and kidney (N¼133), and 538
healthy controls, assessing dietary acrylamide by linking extensive food frequency data with acrylamide levels in certain food items
recorded by the Swedish National Food Administration. Unconditional logistic regression was used to estimate odds ratios, adjusting
for potential confounders. We found consistently a lack of an excess risk, or any convincing trend, of cancer of the bowel, bladder, or
kidney in high consumers of 14 different food items with a high (range 300–1200mgkg
 1) or moderate (range 30–299mgkg
 1)
acrylamide content. Likewise, when we analysed quartiles of known dietary acrylamide intake, no association was found with cancer
of the bladder or kidney. Unexpectedly, an inverse trend was found for large bowel cancer (P for trend 0.01) with a 40% reduced risk
in the highest compared to lowest quartile. We found reassuring evidence that dietary exposure to acrylamide in amounts typically
ingested by Swedish adults in certain foods has no measurable impact on risk of three major types of cancer. It should be noted,
however, that relation of risk to the acrylamide content of all foods could not be studied.
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Acrylamide is classified by the International Agency for Research
on Cancer (IARC) as a probable human carcinogen (IARC, 1994).
In April 2002, a Swedish food survey created international public
health alarm by its report of substantially elevated levels of
acrylamide in frequently consumed food products (Swedish
National Food Administration (NFA), 2002) and in particular, in
potato crisps, French fries, and crisp bread. Acrylamide formation
probably occurs as a result of a reaction between amino acids and
reducing sugars during the heating of starch-rich foods to high
temperatures (Mottram et al, 2002; Stadler et al, 2002).
Although animal models support a dose–response relation
between acrylamide and cancer at multiple sites (Bull et al, 1984;
Johnson et al, 1986), no epidemiological study to date has
examined whether higher intake of foods containing high
acrylamide level increases the risk of any cancer. The Swedish
NFA findings therefore led to much public concern in Europe and
the United States. In response, we have analysed data from a
population-based case–control study in Sweden to investigate
whether higher intake of certain food items with higher acrylamide
content increases the risk of cancers of the large bowel, bladder, or
kidney.
MATERIALS AND METHODS
Study population
This investigation was undertaken in an existing population-based
case–control study of a possible relation between heterocyclic
amines in fried foods, and cancers of the large bowel and urinary
tract (Augustsson et al, 1999). The study base comprised
individuals born in Sweden between 1918 and 1942, and residing
in Stockholm for at least 1 month between November 1992 and
December 1994. Incident cases were identified in the Stockholm
area from the population-based cancer registry and included the
following sites: large bowel (ICD9 153 and 154), bladder (ICD9
188), and kidney (ICD9 189, excluding renal pelvis 189.1 and
189.3). Controls were randomly selected from the Register of Total
Population during the study period, and frequency matched by age
and gender.
Received 23 September 2002; revised 17 October 2002; accepted 25
October 2002
*Correspondence: Dr LA Mucci, Department of Epidemiology, Harvard
School of Public Health, 677 Huntington Avenue, 9th floor, Boston, MA
02115 USA; E-mail: lmucci@hsph.harvard.edu
British Journal of Cancer (2003) 88, 84 – 89
& 2003 Cancer Research UK All rights reserved 0007– 0920/03 $25.00
www.bjcancer.com
E
p
i
d
e
m
i
o
l
o
g
ySurvey questionnaires were mailed to 692 controls, and 875, 391,
186 cases of cancer of the large bowel, bladder, and kidney,
respectively. As previously described (Augustsson et al, 1999),
participation rates were 80% for controls, and between 68 and 74%
for cases. Reasons for nonparticipation included death, illness,
refusal, or loss of questionnaire. An additional 40 respondents (15
controls and 25 cases) had missing dietary data on 410% of items
and were dropped from the analysis. The sample size for the
current study was 538 controls, and 591, 263, 133 cases with cancer
of the large bowel, bladder and kidney, respectively. This study was
approved by the Ethical Committee of Karolinska Institutet.
Dietary data
Dietary habits in the 5 years prior to the study were assessed by
semiquantitative food frequency questionnaire of 188 food items.
Respondents could choose from 10 intake frequency categories
ranging from two to three times per day to never.
In addition, more than 100 food samples were analysed to
determine acrylamide levels at the NFA. The majority of the foods
found to contain high levels of acrylamide were covered by the
food frequency questionnaire including French fries, potato crisps,
fried potatoes, crisp bread, breakfast cereals, and biscuits. A
summary of median acrylamide levels is given in Table 1. The
survey found that foodstuffs that were not fried, deep fried, or
oven-baked during production or preparation did not contain any
appreciable levels of acrylamide.
A summary measure of acrylamide dose was determined by
ranking the following food items on acrylamide dose: potato
crisps, French fries, fried potatoes, fried pancakes, pizza, meat-
balls, breaded fish, cereals, crisp and soft bread, and biscuits. The
foodstuffs were ranked according to the median acrylamide
content determined by the Swedish NFA as follows: food stuffs
without appreciable acrylamide were assigned a rank of 0; food
stuffs with a median acrylamide content less than 100mgkg
 1 were
assigned a rank of 1; those with a median acrylamide dose 100–
200mgkg
 1 were assigned a rank of 2; those with a median
acrylamide dose 200–600mgkg
 1 were assigned a rank of 4; and
those with a median acrylamide dose greater than 600mgkg
 1
were assigned a rank of 8. We converted an individual’s intake
of each food item to grams per day, multiplied this by the
acrylamide level ranking for the specific food item, and summed
up the ranks across all of the above foods items for each
individual.
Statistical analysis
We assessed the risk of each cancer separately for 14 food items
found to contain high acrylamide levels (median 440mgkg
 1) and
for the total summary measure of dietary acrylamide. Uncondi-
tional logistic regression was employed to calculate odds ratios
(OR), an estimate of the rate ratio, and 95% confidence intervals
(95% CI).
Quartiles of the summary acrylamide measure were created
based on the distribution of the control group, and modelled as
categorical variables with the lowest quartile as referent group.
Breads were modelled as servings per day. Tests for trend were
calculated using likelihood ratio tests, where the categorical
medians of each quartile were modelled as ordinal covariates. In
multivariate models, we considered as potential confounders
smoking (current, former, never), body mass index (categorical),
alcohol intake (categorical-colorectal cancer only), fruit and
vegetable intake (continuous), saturated fat density (quintiles,
categorical), red meat density (quintiles, categorical), and total
energy (log transformed). Variables that were statistically sig-
nificant at a¼0.20, or which confounded the relation between
acrylamide and cancer, were included in the final model (Rothman
and Greenland, 1998). Since smoking contributes appreciably to
acrylamide exposure, we examined possible differences in cancer
risk among smokers and nonsmokers through stratification and
through adding interaction term(s) in the models.
Finally, a sensitivity analysis was performed to examine the
extent of misclassification by using the median acrylamide
concentrations to rank food items and calculate total dietary
acrylamide dose. In this approach, we calculated summary
measures by reranking individual food items based alternatively
on the minimum and maximum acrylamide content measured in
the Swedish NFA samples. All statistical analyses were performed
using SAS version 8.2.
RESULTS
Lifestyle and dietary characteristics of cases and controls are
shown in Table 2. Weekly intake of French fries and potato crisps
by both cases and controls was low, while intake of pan-fried
potatoes was more common. About one-fifth of controls consumed
three or more slices of crisp bread per day. These data suggest that
bread products and pan-fried potatoes account for a major source
of dietary acrylamide. Estimated mean daily intake of acrylamide
through diet was 27.5mg among controls, based on foodstuffs
investigated by the Swedish NFA as of April 2002.
The association between foodstuffs containing high acrylamide
levels and risk of cancers of the large bowel and urinary tract is
presented in Table 3. Controlling for potential confounders, there
is little evidence of an association between any specific baked or
fried potato product and cancer risk. While the data suggest a
higher risk of bladder cancer for those with daily intake of any
fried or baked potatoes (adjusted OR 1.6 (95% CI 0.7–3.5)), wide
CIs preclude definitive assessment. There is no evidence of a
positive association between crisp breads and cancer risk. Indeed,
the relation between crisp bread and large bowel cancer risk
appeared to be inverse (P for trend¼0.07). No other breads or
cereals were related, inversely or positively, with risk of cancer of
the large bowel, bladder or kidney. With respect to other fried
foods, the data suggest a small increase in risk of large bowel
cancer with increasing consumption of breaded fish (P for
trend¼0.11). No other fried food items are associated with risk
of the studied cancers.
The relative risk of cancer comparing quartiles of daily dietary
acrylamide intake based on ranking of food items is presented in
Table 4. For colorectal cancer, the risk of cancer decreases with
increasing quartiles of acrylamide through diet (P for tren-
d¼0.01). After adjusting for potential confounders, the risk of
Table 1 Acrylamide concentration for several food groups: Swedish
National Food Administration, 2002
Acrylamide
concentration (mgkg
 1)
Number of
Food group Median Min–max samples
Potato crisps 1200 330–2300 14
French fries 450 300–1100 9
Pan-fried potatoes 300 1
Biscuits and crackers 410 o30–650 14
Crisp breads 140 o30–1900 21
Breakfast cereals 160 o30–1400 15
Corn chips 150 120–180 3
Soft breads 50 o30–160 20
Various fried foods (pizza, pancakes,
waffles, fish fingers, meatballs,
chickenbits, deep fried fish, vegetarian
schnitzel, and cauliflower gratin)
40 o30–60 9
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acrylamide per day was 40% lower compared to those consuming
in the lowest quartile. The inverse association with large bowel
cancer was evident among nonsmokers (adjusted OR¼0.6
comparing highest to lowest quartile; P for trend¼0.03) and
suggestive among smokers (adjusted OR¼0.7 comparing highest
to lowest quartile; P for trend¼0. 50). The relative risk between
dietary acrylamide dose and cancers of the bladder and kidney was
essentially null, and was similar for smokers and nonsmokers.
The findings in Table 4 were unaffected by the acrylamide
concentration standard used to rank the food items, that is, using
the median concentration vs the minimum or maximum
concentration. Comparing the highest to lowest quartile, the
relative risk of colorectal cancer was 0.6 using the median
concentration, 0.6 using the minimum, and 0.7 using the
maximum acrylamide concentration based on the NFA data. The
relative risk estimates for bladder and kidney cancers were also
unaffected by the acrylamide concentration used in rankings (data
available on request).
DISCUSSION
The finding in April 2002 of elevated levels of acrylamide in a
variety of foodstuffs were unexpected, and led to a call by public
health scientists for additional research on acrylamide (WHO,
2002). Reports from laboratory studies a few months later have
provided insight into the biochemical mechanism of acrylamide
formation. Acrylamide can be generated during the heating of
specific foodstuffs as a result of a Maillard reaction between amino
acids and sugars (Mottram et al, 2002; Stadler et al, 2002). In
particular, acrylamide formation occurs when the amino acid
asparagine, in the presence of sugars, is heated above 1001C.
Potatoes and cereals, which had the highest measured levels of
acrylamide in the Swedish NFA survey, are rich in asparagine
(Belitz and Grosch, 1999).
This population-based case–control study found no association
between dietary exposure to acrylamide in amounts typically
ingested by Swedish adults and risk of cancers of the large bowel,
bladder, or kidney. For foods with the highest acrylamide levels,
namely, potato crisps, French fries, and crisp bread, there was no
positive association with cancer risk. Indeed, the risk of cancer of
the large bowel decreased with increasing dose of dietary
acrylamide. We did observe a slightly higher risk of bladder
cancer for those consuming baked or fried potatoes daily
compared to never, although the CI includes the null value.
Although this positive finding is in line with a previous study
(Steineck et al, 1990), our findings overall suggest that components
of potatoes other than acrylamide are responsible for this
association.
The classification of acrylamide by IARC as a probable human
carcinogen (IARC, 1994) was based mainly on in vitro and animal
models. Acrylamide induces genetic mutations and chromosomal
abnormalities in vitro, and cellular transformation in vivo (IARC,
Table 2 Distribution of demographic, lifestyle and dietary factors among controls and cases of large bowel, bladder and kidney cancer
Controls Cancer cases of large bowel Cancer cases of bladder Cancer cases of kidney
N (%) N (%) N (%) N (%)
Characteristics of participants
Gender
Males 272 (50.6%) 346 (58.5%) 199 (75.7%) 71 (53.4%)
Females 266 (49.4%) 245 (41.5%) 64 (24.3%) 62 (46.6%)
Age group (years)
51–62 141 (26.2%) 167 (28.3%) 54 (20.5%) 45 (33.8%)
63–68 130 (24.2%) 137 (23.2%) 77 (29.3%) 30 (22.6%)
69–72 137 (25.5%) 137 (23.2%) 64 (24.3%) 35 (26.3%)
73–77 130 (24.2%) 150 (25.4%) 68 (25.9%) 23 (17.3%)
Body mass index (kgm
 2) >25.0 205 (38.5%) 316 (53.8%) 140 (53.5%) 70 (53.4%)
Current smokers 130 (24.2%) 134 (22.7%) 128 (48.7%) 34 (25.6%)
Food intake 5 years prior
Weekly consumption of
French fries 33 (6.1%) 58 (9.8%) 23 (8.8%) 36 (34.6%)
Potato crisps 54 (10.0%) 48 (8.1%) 14 (5.3%) 16 (11.3%)
Pan-fried potatoes 202 (37.6%) 226 (38.2%) 124 (47.2%) 49 (36.8%)
Potatoes au gratin 42 (7.8%) 59 (10.0%) 17 (6.5%) 15 (11.3%)
Cornflakes 186 (34.6%) 161 (27.2%) 66 (25.1%) 31 (23.3%)
Muesli 172 (32.4%) 168 (28.8%) 70 (27.0%) 42 (31.8%)
Oatmeal 244 (45.3%) 211 (35.8%) 88 (33.5%) 46 (34.6%)
Biscuits 257 (47.8%) 302 (51.2%) 123 (47.0%) 66 (49.6%)
Fried meatballs 54 (10.0%) 50 (8.5%) 27 (10.3%) 19 (14.3%)
Breaded fish 100 (19.5%) 132 (23.7%) 55 (22.1%) 30 (24.0%)
Pancakes/waffles 181 (33.6%) 193 (32.7%) 80 (30.4%) 43 (32.3%)
3+ slices per day of
Crisp bread 104 (21.2%) 117 (19.8%) 57 (12.2%) 28 (31.0%)
Rye bread 45 (8.3%) 63 (10.6%) 35 (13.3%) 15 (11.3%)
White bread 54 (10.0%) 61 (10.3%) 26 (9.9%) 20 (15.0%)
Other dietary factors Mean (SE) Mean (SE) Mean (SE) Mean (SE)
Fruit and vegetables (gday
 1) 275.3 (8.2) 250.1 (6.8) 234.9 (11.1) 260.6 (15.2)
Saturated fat (gday
 1) 35.5 (0.7) 38.1 (0.7) 40.4 (1.3) 36.8 (1.5)
Total calories (kcalday
 1) 2065.9 (27.5) 2186.4 (29.3) 2243.0 (49.4) 2150.3 (62.9)
Alcohol (gday
 1) 10.8 (0.6) 11.8 (0.6) 15.2 (1.1) 10.8 (1.4)
Acrylamide intake through diet (mgday
 1) 27.5 (0.6) 28.6 (0.6) 29.4 (0.9) 28.4 (1.2)
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Cancer of large bowel Cancer of bladder Cancer of kidney
Adjusted
a Adjusted
b Adjusted
a Adjusted
b Adjusted
a Adjusted
b
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Potatoes
French Fries (high levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 1.3 (1.0–1.7) 1.3 (0.9–1.7) 1.1 (0.7–1.5) 0.8 (0.5–1.3) 0.9 (0.6–1.5) 0.9 (0.5–1.4)
2–3 times per month 0.9 (0.6–1.3) 0.8 (0.6–1.2) 0.8 (0.5–1.4) 1.0 (0.6–1.6) 0.9 (0.5–1.6) 0.7 (0.4–1.4)
Weekly 0.9 (0.6–1.5) 0.8 (0.5–1.4) 0.7 (0.4–1.3) 0.7 (0.4–1.1) 0.9 (0.4–1.8) 0.7 (0.3–1.6)
Potato crisps (high levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 1.3 (1.0–1.7) 1.3 (1.0–1.7) 1.2 (0.9–1.7) 1.2 (0.8–1.7) 1.6 (1.1–2.4) 1.7 (1.1–2.6)
2–3 times per month 0.9 (0.6–1.4) 0.8 (0.5–1.3) 1.2 (0.7–2.1) 1.3 (0.7–2.3) 0.9 (0.4–1.9) 0.9 (0.4–1.9)
Weekly 1.4 (0.8–2.2) 1.3 (0.8–2.1) 0.9 (0.5–1.8) 0.9 (0.4–1.8) 0.8 (0.3–2.0) 0.7 (0.3–1.9)
Pan-Fried Potatoes (high levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 1.0 (0.7–1.6) 1.0 (0.6–1.5) 1.1 (0.6–2.0) 1.1 (0.5–2.1) 0.8 (0.4–1.6) 0.7 (0.4–1.5)
2–3 times per month 1.0 (0.6–1.6) 0.9 (0.5–1.4) 1.2 (0.6–2.3) 1.2 (0.6–2.3) 0.9 (0.5–1.8) 0.8 (0.4–1.7)
Weekly 1.0 (0.6–1.5) 0.8 (0.5–1.2) 1.4 (0.8–2.5) 1.3 (0.7–2.4) 0.8 (0.4–1.6) 0.7 (0.4–1.4)
Potatoes au Gratin (unknown levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 1.1 (0.7–1.7) 1.2 (0.8–1.8) 0.7 (0.4–1.1) 0.7 (0.4–1.1) 0.8 (0.4–1.5) 0.8 (0.4–1.5)
2–3 times per month 1.1 (0.7–1.7) 1.2 (0.7–1.9) 0.7 (0.4–1.2) 0.7 (0.4–1.3) 0.8 (0.4–1.5) 0.8 (0.4–1.7)
Weekly 1.3 (0.8–2.3) 1.5 (0.8–2.7) 0.5 (0.2–1.1) 0.5 (0.2–1.0) 1.0 (0.4–2.4) 1.1 (0.4–2.6)
Total potatoes fried or baked
Less often/Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
2–3 per month 1.0 (0.7–1.4) 0.9 (0.6–1.2) 1.2 (0.7–1.9) 1.2 (0.7–2.0) 1.1 (0.6–1.8) 1.0 (0.6–1.8)
Weekly 0.8 (0.6–1.1) 0.7 (0.5–1.0) 1.2 (0.8–1.9) 1.1 (0.7–1.8) 0.9 (0.5–1.4) 0.7 (0.4–1.3)
Daily 1.6 (0.9–2.7) 1.2 (0.6–2.2) 1.7 (0.8–3.4) 1.6 (0.7–3.5) 1.1 (0.4–2.7) 0.8 (0.3–2.2)
Bread
Crisp bread (moderate levels)
None 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
1–2 slices per day 1.0 (0.7–1.4) 1.0 (0.7–1.4) 0.9 (0.6–1.3) 0.8 (0.5–1.2) 1.0 (0.6–1.7) 0.9 (0.6–1.6)
3 slices per day 0.9 (0.6–1.4) 0.8 (0.5–1.3) 0.7 (0.4–1.2) 0.6 (0.3–1.2) 0.7 (0.7–1.6) 0.6 (0.3–1.5)
4+ slices per day 0.8 (0.5–1.3) 0.7 (0.4–1.1) 0.9 (0.5–1.6) 0.7 (0.4–1.4) 1.3 (0.6–2.6) 1.2 (0.6–2.5)
Rye bread (moderate levels)
None 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
1–2 slices per day 1.0 (0.8–1.3) 0.9 (0.7–1.2) 0.8 (0.5–1.0) 0.7 (0.5–1.0) 1.0 (0.7–1.5) 0.9 (0.6–1.4)
3 slices per day 1.6 (0.9–3.0) 1.5 (0.8–2.8) 1.3 (0.6–2.7) 1.4 (0.6–3.0) 1.7 (0.7–4.3) 1.7 (0.7–4.5)
4+ slices per day 0.9 (0.5–1.6) 0.7 (0.4–1.3) 1.0 (0.6–2.0) 0.9 (0.5–1.8) 1.3 (0.6–3.0) 1.2 (0.5–2.9)
White bread (moderate levels)
None 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
1–2 slices per day 1.3 (1.0–1.7) 1.2 (0.9–1.6) 1.2 (0.9–1.7) 1.0 (0.7–1.5) 0.9 (0.6–1.3) 0.8 (0.5–1.3)
3 slices per day 1.5 (0.8–2.7) 1.3 (0.7–2.3) 0.9 (0.4–2.0) 0.7 (0.3–1.8) 1.8 (0.8–4.3) 1.7 (0.7–4.1)
4+ slices per day 0.9 (0.6–1.6) 0.7 (0.4–1.3) 0.9 (0.5–1.8) 0.6 (0.3–1.3) 1.3 (0.6–2.7) 1.0 (0.5–2.3)
Cereal
Cornflakes (moderate levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 1.5 (1.1–2.0) 1.5 (1.1–2.0) 1.0 (0.7–1.4) 0.9 (0.6–1.3) 1.0 (0.6–1.7) 0.9 (0.6–1.6)
2–3 times per month 1.0 (0.7–1.6) 0.9 (0.6–1.5) 1.0 (0.6–1.7) 0.9 (0.5–1.7) 1.4 (0.7–2.6) 1.3 (0.7–2.6)
1–2 per week 1.3 (0.9–1.9) 1.3 (0.9–1.9) 0.9 (0.6–1.5) 0.8 (0.5–1.3) 1.1 (0.6–2.0) 1.0 (0.6–1.9)
3+ per week 1.3 (0.9–1.9) 1.2 (0.8–1.9) 1.1 (0.6–1.8) 1.0 (0.6–1.8) 0.8 (0.4–1.6) 0.8 (0.4–1.6)
Muesli (moderate levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 0.9 (0.7–1.2) 1.0 (0.7–1.4) 0.6 (0.4–0.9) 0.7 (0.5–1.2) 0.8 (0.4–1.3) 0.8 (0.5–1.3)
2–3 times per month 1.3 (0.7–2.6) 1.3 (0.7–2.7) 0.9 (0.3–2.4) 0.9 (0.3–2.8) 1.2 (0.4–3.5) 1.2 (0.4–3.7)
1–2 per week 0.9 (0.6–1.4) 1.0 (0.7–1.6) 0.9 (0.6–1.5) 1.1 (0.6–1.8) 1.1 (0.6–1.9) 1.2 (0.6–2.2)
3+ per week 1.0 (0.7–1.4) 1.1 (0.7–1.6) 0.8 (0.5–1.3) 1.0 (0.6–1.7) 1.0 (0.6–1.7) 1.1 (0.6–2.0)
Various fried foods
Biscuits (high levels)
Less often/never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
2–3 per month 1.2 (0.9–1.6) 1.1 (0.8–1.5) 0.9 (0.6–1.3) 1.0 (0.6–1.5) 1.0 (0.6–1.6) 1.0 (0.6–1.6)
Weekly 1.1 (0.8–1.6) 1.0 (0.7–1.4) 1.2 (0.7–1.8) 1.3 (0.8–2.1) 0.9 (0.5–1.6) 0.9 (0.5–1.7)
Daily 1.1 (0.7–1.6) 0.9 (0.6–1.4) 0.9 (0.5–1.4) 0.9 (0.5–1.7) 1.5 (0.8–2.6) 1.4 (0.7–2.6)
Meatballs (moderate levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 0.6 (0.3–1.3) 0.5 (0.2–1.2) 1.7 (0.5–8.3) 0.7 (0.1–3.9) 0.5 (0.2–1.7) 0.4 (0.1–1.4)
2–3 times per month 0.7 (0.3–1.5) 0.6 (0.3–1.3) 2.3 (0.5–10.9) 0.9 (0.2–4.8) 0.6 (0.2–2.0) 0.4 (0.1–1.4)
Weekly 0.6 (0.2–1.3) 0.4 (0.2–1.1) 2.0 (0.4–10.2) 0.8 (0.1–4.8) 0.9 (0.3–3.2) 0.5 (0.2–2.0)
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exposure relation between acrylamide and risk of cancer of the
lung, mammary gland, thyroid, oral cavity, and intestinal and
reproductive tract (Bull et al, 1984; Johnson et al, 1986). Moreover,
animals administered acrylamide orally (Paulsson et al, 2002) or
fed a diet high in fried foods (Tareke et al, 2000) had higher levels
of haemoglobin DNA adducts compared to unexposed animals.
The human data were less clear and limited to occupational
settings. In a small cohort of 371 workers exposed to acrylamide
through organic dyes, cancer mortality was higher than expected,
mainly because of deaths from cancer of the digestive tract and
respiratory system (Sobel et al, 1986). More recently, Marsh et al
(1999) in a cohort of 8500 workers with potential occupational
exposure found little evidence for an excess risk of cancer
mortality overall. While an excess of thyroid cancer and a dose–
exposure relation with pancreatic cancer were suggested, the wide
CIs precluded definitive assessments. The study had greater power
to detect an effect of lung cancer, which showed minimal excess
risk between both workers exposed and unexposed to acrylamide
compared to the general population. Among 200 construction
workers exposed to high levels of acrylamide for 20 months, 80%
had haemoglobin adduct levels above the normal background
range (Hagmar et al, 2001).
One interpretation of our null finding is that no association
between dietary acrylamide and cancer risk exists, implying that
species differences negate extrapolating from experimental ani-
mals to humans, as shown for other carcinogens (IARC, 1987). In
addition, human intake of dietary acrylamide is several folds lower
than doses tested in animal experiments. Acrylamide intake within
the range of human exposure may thus be effectively detoxified.
Although a comprehensive coverage of dietary acrylamide was not
possible, certain aspects of our study would support the validity of
Breaded fish (moderate levels)
Never ** ** ** ** ** **
Less often 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
2–3 times per month 1.2 (0.9–1.6) 1.2 (0.9–1.5) 1.4 (0.9–2.0) 1.4 (0.9–2.1) 0.9 (0.6–1.5) 0.9 (0.6–1.4)
Weekly 1.4 (1.0–2.0) 1.3 (0.9–1.9) 1.4 (0.9–2.1) 1.2 (0.7–2.0) 1.3 (0.7–2.1) 1.1 (0.6–2.0)
Pancakes/waffles (moderate levels)
Never 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Less often 1.6 (0.9–3.0) 1.7 (0.9–3.4) 1.0 (0.5–2.1) 1.2 (0.6–2.7) 2.0 (0.6–6.1) 2.6 (0.7–9.4)
2–3 times per month 1.4 (0.7–2.5) 1.3 (0.7–2.5) 0.8 (0.4–1.5) 0.9 (0.4–1.9) 1.5 (0.5–4.5) 1.7 (0.5–6.1)
Weekly 1.3 (0.7–2.5) 1.2 (0.6–2.3) 0.7 (0.4–1.4) 0.7 (0.3–1.6) 1.5 (0.5–4.6) 1.6 (0.4–5.9)
aAdjusted for matching factors age and gender.
bAlso adjusted for smoking (current, former, never), BMI (categorical), alcohol intake (categorical-colorectal cancer only), fruit and
vegetable intake (continuous), saturated fat density (quintiles, categorical), red meat density (quintiles, categorical), and total energy (log transformed). **No cases or controls
never consumed breaded fish products.
Table 3 (continued)
Cancer of large bowel Cancer of bladder Cancer of kidney
Adjusted
a Adjusted
b Adjusted
a Adjusted
b Adjusted
a Adjusted
b
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Table 4 Quartiles of daily dietary acrylamide dose based on ranking of food items and risk of cancer of the large bowel, bladder and kidney
Cancer of large bowel Cancer of bladder Cancer of kidney
Quartiles of ranked
daily acrylamide intake
Adjusted
a
OR (95% CI)
Adjusted
b
OR (95% CI)
Adjusted
a
OR (95% CI)
Adjusted
b
OR (95% CI)
Adjusted
a
OR (95% CI)
Adjusted
b
OR (95% CI)
Overall
Quartile 1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Quartile 2 1.0 (0.74–1.45) 0.9 (0.6–1.3) 1.3 (0.8–2.1) 1.1 (0.7–1.8) 1.0 (0.6–1.8) 1.0 (0.6–1.9)
Quartile 3 0.9 (0.63–1.26) 0.6 (0.4–0.9) 1.0 (0.6–1.5) 0.7 (0.4–1.3) 1.2 (0.7–2.0) 1.1 (0.6–2.0)
Quartile 4 1.0 (0.71–1.42) 0.6 (0.4- 1.0) 1.2 (0.7–1.9) 0.8 (0.5–1.5) 1.0 (0.6–1.8) 0.8 (0.4–1.7)
P-value for trend 0.80 0.01 0.87 0.26 0.88 0.64
Nonsmokers
Quartile 1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Quartile 2 1.0 (0.7–1.5) 0.9 (0.6–1.3) 1.4 (0.8–2.5) 1.0 (0.6–2.0) 1.0 (0.5–1.9) 1.0 (0.5–2.0)
Quartile 3 0.9 (0.6–1.3) 0.6 (0.4–0.9) 0.8 (0.5–1.6) 0.6 (0.3–1.2) 1.1 (0.6–2.1) 0.9 (0.4–1.9)
Quartile 4 1.1 (0.8–1.7) 0.6 (0.3–1.0) 1.2 (0.6–2.2) 0.7 (0.3–1.6) 1.0 (0.5–1.9) 0.7 (0.3–1.7)
P-value for trend 0.69 0.03 0.99 0.20 0.99 0.41
Current smokers
Quartile 1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Quartile 2 1.1 (0.5–2.1) 1.1 (0.5–2.3) 1.2 (0.6–2.6) 1.1 (0.5–2.5) 1.3 (0.4–4.5) 1.2 (0.3–4.6)
Quartile 3 0.9 (0.4–1.9) 0.9 (0.4–2.1) 1.3 (0.6–2.8) 1.1 (0.5–2.5) 1.8 (0.5–5.9) 1.5 (0.4–6.2)
Quartile 4 0.7 (0.4–1.5) 0.7 (0.3–2.1) 1.0 (0.5–2.2) 1.0 (0.4–2.3) 1.2 (0.4–4.1) 1.3 (0.2–6.3)
P-value for trend 0.31 0.51 0.99 0.88 0.74 0.72
aAdjusted for matching factors age and gender.
bAlso adjusted for smoking (current, former, never), BMI (categorical), alcohol intake (categorical-colorectal cancer only), fruit and
vegetable intake (continuous), saturated fat density (quintiles, categorical), red meat density (quintiles, categorical), and total energy (log transformed).
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reasonably high response rates, thus reducing the possibility of
selection bias while the data on demographic, lifestyle, and dietary,
covariates would have reduced the opportunity for confounding in
the analysis.
Could certain limitations and possible biases have attenuated a
true positive association? First, the acrylamide content of a number
of food items has not yet been characterised, so our values of daily
intake of dietary acrylamide may be underestimated. Measurement
errors of acrylamide intake in cases and controls would entail such
attenuation (Rothman and Greenland, 1998). There was also
variability in acrylamide dose across brands of a given food. It is
relevant that it is ranking of individuals with respect to exposure,
rather than absolute intake, that determines the calculated relative
risk in case–control studies. In fact, when comparing an
abbreviated vs extensive food frequency questionnaire, increasing
the number of food items improves the ranking, and thereby the
relative risk, only to a small degree (Voskuil et al, 1999). In our
own data, we found the relative risk estimates comparing quartiles
of total acrylamide dose to be insensitive to the concentration of
acrylamide used to rank individual food items. Although we
possibly capture only partial intake of acrylamide, it is likely that
we have a ranking that is valid for drawing conclusions.
Second, a true association may be concealed if the level of
exposure in the studied population is low and/or if the range of
variation is limited. Of the food items found to contain the highest
levels of acrylamide, only biscuits and pan-fried potatoes were
commonly consumed by this population. Risk assessment models
for humans suggest that lifetime risk for cancer is 0.7–4.5 per 1000
based on consumption of 1mg acrylamide per kg body weight per
day (US EPA, 1985; WHO, 1985). In our study, less than 2% of the
population was estimated to intake acrylamide through diet at
these levels. Acrylamide intake through dietary sources may thus
be effectively detoxified within the range of human exposure. This
hypothesis is suggested for heterocyclic amines, which cause
cancer when given to rodents, but does not appear to in humans,
where doses are typically millionth of those given in studies of
animal carcinogenicity (Augustsson et al, 1999).
Third, residual confounding is a possible explanation for some
of our findings, such as the inverse association between total
acrylamide dose and large bowel cancer. The food items under
study contain a multitude of nutrients. Although we have
controlled analytically for total energy, saturated fat, meat, and
fruits and vegetables, it may be difficult to disentangle the
protective effect of specific nutrients from that of acrylamide.
Lastly, although no excess risk was observed for the three major
cancers studied, we cannot rule out a possible excess risk of other
cancer sites. However, large bowel, bladder, and kidney would be
likely target sites, because acrylamide and its metabolite glycida-
mide are detoxified by glutathione conjugation, are water soluble,
and are absorbed quickly in the digestive tract and excreted via the
urine (IARC, 1994).
This first study of dietary acrylamide in relation to three major
human cancers is reassuring. Needless to say, additional epide-
miological evidence is required, notably for other cancer sites as
well as for neurological and other disorders. While the null
hypothesis of no effect can never be scientifically proven, it would
be useful to determine cooking methods that avoid acrylamide
formation during food preparation. Since measuring error in
acrylamide intake would entail underestimation of any true
association with cancer risk, validation studies of acrylamide dose
using existing food questionnaires should be a high priority.
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